Lunit-Medical AI Software-Cancer Screening-Treatment Response Prediction-Lunit Medical AI Software

Lunit is a publicly traded company specializing in the development of medical AI software, with a focus on combating cancer. The company's main emphasis is on assisting doctors in early cancer detection, as timely diagnosis plays a crucial role in determining patient survival rates. Lunit's cancer screening AI, known as Lunit INSIGHT, demonstrates an astonishing accuracy rate of 97-99% in detecting abnormal radiological findings on chest X-rays. Many of these abnormalities are difficult for the human eye to perceive, making them challenging for doctors to detect without Lunit's technology. Additionally, Lunit SCOPE utilizes AI to predict treatment response, enabling doctors to make informed decisions and develop personalized treatment plans for patients.

Lunit INSIGHT and Lunit SCOPE are two main modules of Lunit. Lunit INSIGHT utilizes AI technology to assist doctors in achieving higher accuracy in early cancer detection, particularly in chest X-ray examinations. Lunit SCOPE, on the other hand, uses AI to predict patients' treatment responses and helps doctors develop better treatment plans.